Protagenic Therapeutics secures financing
Protagenic Therapeutics entered into a securities purchase agreement to sell to investors, thereby raising capital.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed